In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

(HealthDay News) — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online in ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data ...

The ACS has released cancer statistics for 2025 suggesting that more than 2 million new cases of cancer will be diagnosed in the US this year.

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...

Among management options for node-positive upper tract urothelial cancer (UTUC), induction chemotherapy added to radical nephroureterectomy (RNU) provides the best cancer control and survival outcomes ...

Efforts to limit access to the abortion drug mifepristone have received a boost from a federal judge who took the bench during President Donald Trump’s first term. US District Judge Matthew Kacsmaryk ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

(HealthDay News) — Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news ...

A meta-analysis showed risk for heart failure in men with prostate cancer receiving ADT was higher in Asian studies that in North American studies.

Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa ...